.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Accenture
Argus Health
Federal Trade Commission
Chinese Patent Office
Fuji
Deloitte
US Department of Justice
Cantor Fitzgerald
Dow

Generated: June 23, 2017

DrugPatentWatch Database Preview

Potassium chloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for potassium chloride and what is the scope of potassium chloride patent protection?

Potassium chloride
is the generic ingredient in thirty-nine branded drugs marketed by Fresenius Kabi Usa, Lupin Ltd, Baxter Hlthcare, Abraxis Pharm, Actavis Labs Fl Inc, Hospira, Upsher-smith Labs, Watson Labs, Kremers Urban Pharms, Lehigh Valley, Copley Pharm, Pharma Res Software, Gd Searle Llc, Luitpold, Upsher Smith Labs, Savage Labs, Amneal Pharms, Novel Labs Inc, Sigmapharm Labs Llc, Teva, Nesher Pharms, Schering, Tris Pharma Inc, PII, Apothecon, Kv Pharm, Icu Medical Inc, Pharma Serve Ny, Glenmark Pharms Ltd, Mylan Pharms Inc, Intl Medication, Adare Pharms Inc, Lilly, B Braun, Novartis, Abbvie, Paddock Llc, Anchen Pharms, Akorn, Miles, and Future Pak, and is included in eighty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two hundred and twenty-seven drug master file entries for potassium chloride. Seventy-three suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: potassium chloride

Tradenames:39
Patents:1
Applicants:41
NDAs:80
Drug Master File Entries: see list227
Suppliers / Packagers: see list73
Bulk Api Vendors: see list127
Clinical Trials: see list963
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:potassium chloride at DailyMed

Pharmacology for Ingredient: potassium chloride

Tentative approvals for POTASSIUM CHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe20MEQTablet; Oral
► Subscribe► Subscribe10MEQTablet, Extended Release; Oral
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Miles
POTASSIUM CHLORIDE
potassium chloride
INJECTABLE;INJECTION080195-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sigmapharm Labs Llc
POTASSIUM CHLORIDE
potassium chloride
TABLET, EXTENDED RELEASE;ORAL207528-001Aug 19, 2016AB2RXNoNo► Subscribe► Subscribe
Glenmark Pharms Ltd
POTASSIUM CHLORIDE
potassium chloride
TABLET, EXTENDED RELEASE;ORAL203562-002Jul 26, 2016AB1RXNoNo► Subscribe► Subscribe
Glenmark Pharms Ltd
POTASSIUM CHLORIDE
potassium chloride
TABLET, EXTENDED RELEASE;ORAL203562-001Jul 26, 2016AB1RXNoNo► Subscribe► Subscribe
Teva
POTASSIUM CHLORIDE
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL073531-001Apr 26, 1996DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: potassium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
POTASSIUM CHLORIDE
potassium chloride
TABLET, EXTENDED RELEASE;ORAL019439-001Jun 13, 19864,863,743► Subscribe
Kv Pharm
MICRO-K LS
potassium chloride
FOR SUSPENSION, EXTENDED RELEASE;ORAL019561-003Aug 26, 19884,259,315► Subscribe
Nesher Pharms
MICRO-K
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL018238-001Approved Prior to Jan 1, 19824,259,315► Subscribe
Apothecon
KLOTRIX
potassium chloride
TABLET, EXTENDED RELEASE;ORAL017850-001Approved Prior to Jan 1, 19824,140,756► Subscribe
Schering
POTASSIUM CHLORIDE
potassium chloride
TABLET, EXTENDED RELEASE;ORAL019439-002Jun 13, 19864,863,743► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
QuintilesIMS
Cantor Fitzgerald
McKesson
Moodys
Citi
Express Scripts
Harvard Business School
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot